Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Publication Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…Certara2020 年 7 月 14 日
Local Therapies for the Global COVID-19 Pandemic Blog Local Therapies for the Global COVID-19 Pandemic Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…Certara2020 年 5 月 29 日
Applying decision analysis to drug development for COVID-19 & future pandemics Blog Applying decision analysis to drug development for COVID-19 & future pandemics This blog discusses how decision analysis approaches can help drug developers to better decisions under…Certara2020 年 4 月 30 日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? 网络研讨会点播 罕见病药物困境:价值大、价格高、准入受限? This webinar will explain how pricing has evolved for the rare disease drug market and…Certara2020 年 2 月 19 日
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Publication Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Certara2020 年 1 月 17 日
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Publication Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingCertara2020 年 1 月 17 日
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases On-Demand Webinar 快速跟踪罕见病药物的创新解决方案 This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…Certara2019 年 8 月 10 日
Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV Poster Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV Certara2019 年 6 月 24 日
Development of Paclitaxel PBPK Model to Predict Tumour Concentration in Cancer Patients Poster Development of Paclitaxel PBPK Model to Predict Tumour Concentration in Cancer Patients Certara2019 年 6 月 24 日
Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies Poster Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies Certara2019 年 6 月 24 日